President Donald Trump signed an executive order the White House says is aimed at "lowering drug prices and stopping foreign ...

Unlike many industries that might never come back, pharma can build more in the U.S.

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

There are many problems with the plan. It ignores the fact, for instance, that generic drugs, which make up 90% of ...

Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

During a Senate Judiciary Committee hearing on Tuesday, Sen. Sheldon Whitehouse (D-RI) spoke about the price of prescription ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations ...

President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The ...

An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...

President demands that drug companies start bringing costs ‘in line’ with those in other nations.

US President Donald Trump has signed an executive order telling drugmakers to cut prices to "most favoured nation" pricing.